UB Paderborn / Katalog / Suche / in CDI

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue

Aging cell, 2018-10, Vol.17 (5), p.e12822-n/a

2018

Volltextzugriff (PDF)

Tolerability of Current Antiretroviral Single-Tablet Regimens

AIDS reviews, 2018-07, Vol.20 (3), p.141

2018

Volltextzugriff (PDF)

Association of ITPA Gene Polymorphisms and the Risk of Ribavirin-Induced Anemia in HIV/Hepatitis C Virus (HCV)-Coinfected Patients Receiving HCV Combination Therapy

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.2987-2993

2012

Volltextzugriff (PDF)

The Molecular Signature of HIV-1-Associated Lipomatosis Reveals Differential Involvement of Brown and Beige/Brite Adipocyte Cell Lineages

PloS one, 2015-08, Vol.10 (8), p.e0136571-e0136571

2015

Volltextzugriff (PDF)

High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients

Metabolism, clinical and experimental, 2017-06, Vol.71, p.163-170

2017

Volltextzugriff (PDF)

Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines

Current HIV research, 2010-10, Vol.8 (7), p.545

2010

Volltextzugriff (PDF)

Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study

PloS one, 2014-02, Vol.9 (2), p.e89088

2014

Volltextzugriff (PDF)

Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study

Clinical nutrition (Edinburgh, Scotland), 2018-08, Vol.37 (4), p.1340-1347

2018

Volltextzugriff (PDF)

Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial

Journal of antimicrobial chemotherapy, 2015-04, Vol.70 (4), p.1139-1145

2015

Volltextzugriff (PDF)

Association of Thymidylate Synthase Gene Polymorphisms with Stavudine Triphosphate Intracellular Levels and Lipodystrophy

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1428-1435

2011

Volltextzugriff (PDF)

Effects of Rilpivirine on Human Adipocyte Differentiation, Gene Expression, and Release of Adipokines and Cytokines

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3369-3375

2012

Volltextzugriff (PDF)

Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes

Life sciences (1973), 2022-11, Vol.308, p.120948-120948, Article 120948

2022

Volltextzugriff (PDF)

Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines

Antiviral research, 2011-08, Vol.91 (2), p.112-119

2011

Volltextzugriff (PDF)

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients

Journal of antimicrobial chemotherapy, 2015-06, Vol.70 (6), p.1825-1832

2015

Volltextzugriff (PDF)

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals

Journal of antimicrobial chemotherapy, 2017-03, Vol.72 (3), p.844-849

2017

Volltextzugriff (PDF)

Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy

Adipocyte, 2022-12, Vol.11 (1), p.143-152

2022

Volltextzugriff (PDF)

Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients

Journal of antimicrobial chemotherapy, 2012-10, Vol.67 (10), p.2479-2486

2012

Volltextzugriff (PDF)

An assessment of the techno-functional and sensory properties of yoghurt fortified with a lipid extract from the microalga Pavlova lutheri

Innovative food science & emerging technologies, 2016-10, Vol.37, p.237-246

2016

Volltextzugriff (PDF)

Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy

Journal of clinical medicine, 2022-01, Vol.11 (3), p.549

2022

Volltextzugriff (PDF)

Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS

Expert opinion on pharmacotherapy, 2013-06, Vol.14 (8), p.1055-1064

2013

Volltextzugriff (PDF)

Does choice of antiretroviral drugs matter for inflammation?

Expert review of clinical pharmacology, 2019-05, Vol.12 (5), p.389-396

2019

Volltextzugriff (PDF)

Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)

Expert opinion on pharmacotherapy, 2021-06, Vol.22 (9), p.1127-1141

2021

Volltextzugriff (PDF)

Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)—associated Lipodystrophy Syndrome and Stavudine-Triphosphate Intracellular Levels in Patients with Stavudine-Based Antiretroviral Regimens

Clinical infectious diseases, 2010-04, Vol.50 (7), p.1033-1040

2010

Volltextzugriff (PDF)

Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled study

Cytokine (Philadelphia, Pa.), 2018-05, Vol.105, p.73-79

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue

Tolerability of Current Antiretroviral Single-Tablet Regimens

Association of ITPA Gene Polymorphisms and the Risk of Ribavirin-Induced Anemia in HIV/Hepatitis C Virus (HCV)-Coinfected Patients Receiving HCV Combination Therapy

The Molecular Signature of HIV-1-Associated Lipomatosis Reveals Differential Involvement of Brown and Beige/Brite Adipocyte Cell Lineages

High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients

Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines

Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study

Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study

Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System

Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial

Association of Thymidylate Synthase Gene Polymorphisms with Stavudine Triphosphate Intracellular Levels and Lipodystrophy

Effects of Rilpivirine on Human Adipocyte Differentiation, Gene Expression, and Release of Adipokines and Cytokines

Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes

Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals

Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy

Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients

An assessment of the techno-functional and sensory properties of yoghurt fortified with a lipid extract from the microalga Pavlova lutheri

Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy

Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS

Does choice of antiretroviral drugs matter for inflammation?

Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)

Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)—associated Lipodystrophy Syndrome and Stavudine-Triphosphate Intracellular Levels in Patients with Stavudine-Based Antiretroviral Regimens

Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled study

Suchergebnisse filtern